Matarin Capital Management, LLC - ARROWHEAD PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 292 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is 1.07 and the average weighting 0.3%.

Links
Filings
External links
Quarter-by-quarter ownership
Matarin Capital Management, LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$12,253,000
+22.6%
193,171
-45.5%
1.17%
+54.9%
Q3 2019$9,994,000
-2.1%
354,632
-7.9%
0.76%
+3.6%
Q2 2019$10,208,000
+157.1%
385,208
+78.0%
0.73%
+152.6%
Q1 2019$3,971,000–216,409–0.29%–
 Download
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2019
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders